Is NBRVF or VICI a better dividend investment in 2026?

NBRVF currently yields 1000000.00% with a 5% 5-year dividend growth rate. VICI yields 6.57% with 8.1% growth. The better choice depends on your goal: NBRVF offers higher current income.

What is the dividend yield difference between NBRVF and VICI?

NBRVF has a forward dividend yield of 1000000.00% ($2.00/share annually). VICI yields 6.57% ($1.78/share annually). The yield gap is 999993.43 percentage points.

Home › Compare › NBRVF vs VICI

NBRVF vs VICI: Dividend Comparison 2026

NBRVF yields 1000000.00% · VICI yields 6.57%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NBRVF wins by $4.7683925249533696e+36M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NBRVF

● Live price

1000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.7683925249533696e+36M

Annual income

$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00

Full NBRVF calculator →

VICI

VICI Properties Inc.

● Live price

6.57%

Share price

$27.12

Annual div

$1.78

5Y div CAGR

44.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$988.8K

Annual income

$623,261.32

Full VICI calculator →

Portfolio growth — NBRVF vs VICI

📍 NBRVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NBRVF	VICI
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NBRVF + VICI cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NBRVF pays

VICI pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NBRVF

Annual income on $10K today (after 15% tax)

$85,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr

VICI

Annual income on $10K today (after 15% tax)

$558.67/yr

After 10yr DRIP, annual income (after tax)

$529,772.12/yr

At 15% tax rate, NBRVF beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NBRVF + VICI for your $10,000?

NBRVF: 50%VICI: 50%

100% VICI50/50100% NBRVF

Portfolio after 10yr

$2.3841962624766848e+36M

Annual income

$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.98%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

NBRVF

No analyst data

Altman Z

-105.0

Piotroski

3/9

VICI

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$31.60

+16.5% upside vs current

Range: $30.00 — $33.00

Altman Z

1.4

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NBRVF buys

VICI buys

No recent congressional trades found for NBRVF or VICI in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNBRVFVICI

Forward yield	1000000.00% ✓	6.57%
Annual dividend / share	$2.00 ✓	$1.78
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	44.3% ✓
Portfolio after 10y	$4.7683925249533696e+36M	$988.8K ✓
Annual income after 10y	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓	$623,261.32
Total dividends collected	$4.7683311610149396e+36M	$948.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: NBRVF vs VICI ($10,000, DRIP)

Year	NBRVF Portfolio	NBRVF Income/yr	VICI Portfolio	VICI Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$11,368	$948.43	+$100.00M → NBRVF
2	$934,786,450,701	$934,679,439,252.34	$13,339	$1,493.16	+$934786.44M → NBRVF
3	$8,165,787,108,578,292	$8,164,786,887,076,042.00	$16,326	$2,426.21	+$8165787108.56M → NBRVF
4	$66,665,884,190,957,650,000	$66,657,146,798,751,470,000.00	$21,123	$4,112.15	+$66665884190957.63M → NBRVF
5	$508,662,171,058,048,100,000,000	$508,590,838,561,963,700,000,000.00	$29,379	$7,368.23	+$508662171058048128.00M → NBRVF
6	$3,627,235,248,428,489,700,000,000,000	$3,626,690,979,905,457,600,000,000,000.00	$44,804	$14,191.64	+$3.62723524842849e+21M → NBRVF
7	$24,173,681,159,150,610,000,000,000,000,000	$24,169,800,017,434,790,000,000,000,000,000.00	$76,658	$29,972.12	+$2.417368115915061e+25M → NBRVF
8	$150,567,402,861,454,640,000,000,000,000,000,000	$150,541,537,022,614,370,000,000,000,000,000,000.00	$150,894	$71,015.81	+$1.5056740286145463e+29M → NBRVF
9	$876,477,100,281,847,600,000,000,000,000,000,000,000	$876,315,993,160,785,800,000,000,000,000,000,000,000.00	$350,814	$193,582.47	+$8.764771002818475e+32M → NBRVF
10	$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00	$988,809	$623,261.32	+$4.7683925249533696e+36M → NBRVF

NBRVF vs VICI: Complete Analysis 2026

NBRVF — Stock

Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for oral and IV administration. It also develops XENLETA that is in Phase I clinical trial for the treatment of pediatric infections, as well as sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated bacterial pneumonia, complicated intra-abdominal infections, hospital-acquired bacterial pneumonia, acute bacterial skin and skin structure infections, osteomyelitis, and prosthetic joint infections. In addition, the company develops CONTEPO, an epoxide antibiotic for use in treating complicated urinary tract infections, as well as is in Phase I clinical trial for peri-operative prophylaxis. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics plc in 2007. Nabriva Therapeutics plc was incorporated in 2005 and is headquartered in Dublin, Ireland.

Full NBRVF Calculator →

VICI — REIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →

📬

Get this NBRVF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NBRVF vs SCHD NBRVF vs JEPI NBRVF vs O NBRVF vs KO NBRVF vs MAIN NBRVF vs NNN NBRVF vs EPRT NBRVF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.